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ABSTRACT 
 
The first method for the [3+2] annulation of donor-acceptor aminocyclopropanes with aldehydes is reported. The 
reaction is catalyzed by iron trichloride on alumina in yields up to 99% and with excellent cis selectivities (up to 
>20:1), and represents a stereoselective and atom economic access to valuable 2-aminotetrahydrofurans, which 
constitute the core of DNA and RNA. 
Donor-acceptor (D-A) cyclopropanes represent 
versatile three-carbons zwitterionic synthons,1 and are 
widely used to assemble carbocycles and heterocycles by 
means of [3+n] annulation reactions.2 Among them, the 
[3+2] reaction with olefins,3 carbonyls4 and imines5 
                                                     
(1) For reviews on D-A cyclopropanes, see: (a) Reissig, H.-U.; 
Zimmer, R. Chem. Rev 2003, 103, 1151. (b) Yu, M.; Pagenkopf, B. L. 
Tetrahedron 2005, 61, 321. (c) Rubin, M.; Rubina, M.; Gevorgyan, V. 
Chem. Rev 2007, 107, 3117. (d) De Simone, F.; Waser, J. Synthesis 
2009, 2009, 3353. Theoretical study: (e) Schneider, T. F.; Werz, D. B. 
Org. Lett. 2011, 13, 1848.  
(2) (a) Carson, C. A.; Kerr, M. A. Chem. Soc. Rev. 2009, 38, 3051. 
(b) Lebold, T. P.; Kerr, M. A. Pure Appl. Chem. 2010, 82, 1797. (c) 
Agrawal, D.; Yadav, V. K. Chem. Comm. 2008, 6471. (d) Ivanova, O. 
A.; Budynina, E. M.; Chagarovskiy, A. O.; Trushkov, I. V.; Melnikov, 
M. Y. J. Org. Chem 2011, 76, 8852.  
(3) Selected examples with silyl enol ethers: (a) Komatsu, M.; 
Suehiro, I.; Horiguchi, Y.; Kuwajima, I. Synlett 1991, 771. (b) Qu, J.-P.; 
Deng, C.; Zhou, J.; Sun, X.-L.; Tang, Y. J. Org. Chem 2009, 74, 7684. 
With enamines: (c) Dolfini, J. E.; Menich, K.; Corliss, P. Tetrahedron 
Lett. 1966, 4421. (d) Berkowitz, W. F.; Grenetz, S. C. J. Org. Chem. 
1976, 41, 10. With indoles: (e) England, D. B.; Kuss, T. D. O.; Keddy, 
R. G.; Kerr, M. A. J. Org. Chem 2001, 66, 4704. (f) Bajtos, B.; Yu, M.; 
Zhao, H.; Pagenkopf, B. L. J. Am. Chem. Soc. 2007, 129, 9631. With 
allyl silanes (g) Sugita, Y.; Yamadoi, S.; Hosoya, H.; Yokoe, I. Chem. 
Pharm. Bull. 2001, 49, 657. (h) Sapeta, K.; Kerr, M. A. Org. Lett. 2009, 
11, 2081.  
represents a valuable tool for the convergent synthesis of 
cyclopentanes, tetrahydrofurans6 and pyrrolidines, 
respectively.  
The annulation of D-A cyclopropanes with carbonyl 
compounds in particular has been hampered for a long 
time by modest diastereoselectivity and the need of 
stoichiometric amounts of a strong Lewis acid (i.e. TiX4, 
                                                                                      
(4) Perspective article: (a) Campbell, M. J.; Johnson, J. S.; Parsons, 
A. T.; Pohlhaus, P. D.; Sanders, S. D. J. Org. Chem. 2010, 75, 6317. 
Pioneering examples: (b) Reissig, H.-U. Tetrahedron Lett. 1981, 22, 
2981. (c) Shimada, S.; Hashimoto, Y.; Sudo, A.; Hasegawa, M.; Saigo, 
K. J. Org. Chem. 1992, 57, 7126. (d) Shimada, S.; Hashimoto, Y.; 
Nagashima, T.; Hasegawa, M.; Saigo, K. Tetrahedron 1993, 49, 1589. 
(e) Shimada, S.; Hashimoto, Y.; Saigo, K. J. Org. Chem. 1993, 58, 
5226. (f) Sugita, Y.; Kawai, K.; Yokoe, I. Heterocycles 2000, 53, 657. 
(g) Sugita, Y.; Kawai, K.; Yokoe, I. Heterocycles 2001, 55, 135. (h) 
Han, Z.; Uehira, S.; Tsuritani, T.; Shinokubo, H.; Oshima, K. 
Tetrahedron 2001, 57, 987. 
(5) Selected examples: (a) Alper, P. B.; Meyers, C.; Lerchner, A.; 
Siegel, D. R.; Carreira, E. M. Angew. Chem., Int. Ed. 1999, 38, 3186. (b) 
Carson, C. A.; Kerr, M. A. J. Org. Chem 2005, 70, 8242. (c) Kang, Y.-
B.; Tang, Y.; Sun, X.-L. Org. Biomol. Chem. 2006, 4, 299. (d) Parsons, 
A. T.; Smith, A. G.; Neel, A. J.; Johnson, J. S. J. Am. Chem. Soc. 2010, 
132, 9688. 
(6) For a review on the synthesis of tetrahydrofurans, see: Wolfe, J. 
P.; Hay, M. B. Tetrahedron 2007, 63, 261. 
SnX4).7 In the last decade, this transformation has been 
the focus of a renewed research effort. In particular, 
Johnson and co-workers developed catalytic methods for 
the highly stereoselective synthesis of tetrahydrofurans 
(THFs) using Lewis acids (i.e. Sn(OTf)2, Hf(OTf)4) under 
mild conditions.8 
In the [3+2] annulation with aldehydes and ketones, D-
A cyclopropanes bearing oxygen donor group(s) were 
most frequently exploited,4b-g,8e but the use of aryl,4a,8a,c 
alkenyl,8b,d alkyl,4a,8d and silylmethyl2c donors has also 
been documented. To the best of our knowledge, this 
transformation has never been reported using D-A 
cyclopropanes substituted with a nitrogen-containing 
donor group instead.9 In fact, aminocyclopropanes are 
generally underrepresented in annulation and cyclization 
reactions,10 despite the abundance of synthetic methods 
for their preparation.11  
The development of [3+2] annulations of 
aminocyclopropanes with aldehydes would constitute an 
important progress in the field, as this reaction allows the 
one-pot, atom-economic assembly of 2-
aminotetrahydrofurans, a common motif in 
"evolutionarily selected” molecules such as nucleosides, 
as well as in synthetic drugs such as AZT (1)12 (Figure 1).  
 
 
Figure 1. Bioactive natural and synthetic compounds containing 
an aminotetrahydrofuran core. 
                                                     
(7) Only two catalytic methods were reported before 2005 : refs 4f-g. 
(8) Enantiospecific annulation: (a) Pohlhaus, P. D.; Johnson, J. S. J. 
Am. Chem. Soc. 2005, 127, 16014. (b) Pohlhaus, P. D.; Sanders, S. D.; 
Parsons, A. T.; Li, W.; Johnson, J. S. J. Am. Chem. Soc. 2008, 130, 
8642. DyKAT: (c) Parsons, A. T.; Johnson, J. S. J. Am. Chem. Soc. 
2009, 131, 3122. With quaternary sterocenters: (d) Smith, A. G.; Slade, 
M. C.; Johnson, J. S. Org. Lett. 2011, 13, 1996. Recently, an example of 
intramolecular annulation was also reported by Wang and co-workers: 
(e) Xing, S., Li, Y., Li, Z., Liu, C., Ren, J. and Wang, Z. Angew. Chem., 
Int. Ed. 2011, doi: 10.1002/anie.201106368. 
(9) For reviews on aminocyclopropanes, see: (a) Gnad, F.; Reiser, O. 
Chem. Rev 2003, 103, 1603. (b) Brackmann, F.; de Meijere, A. Chem. 
Rev 2007, 107, 4493.  
(10) Intermolecular: (a) Wimalasena, K.; Wickman, Heang B.; 
Mahindaratne, Mathew P. D. Eur. J. Org. Chem. 2001, 2001, 3811. (b) 
Tanguy, C.; Bertus, P.; Szymoniak, J.; Larionov, O. V.; de Meijere, A. 
Synlett 2006, 2006, 2339. Intramolecular: (c) Lee, H. B.; Sung, M. J.; 
Blackstock, S. C.; Cha, J. K. J. Am. Chem. Soc. 2001, 123, 11322. (d) 
Larquetoux, L.; Ouhamou, N.; Chiaroni, A.; Six, Y. Eur. J. Org. Chem. 
2005, 2005, 4654. (e) Mangelinckx, S.; De Kimpe, N. Synlett 2006, 
2006, 0369. Applications in total synthesis: (f) Zhang, D.; Song, H.; 
Qin, Y. Acc. Chem. Res. 2011, 44, 447. (g) De Simone, F.; Waser, J. 
Synlett 2011, 2011, 589. 
(11) Recent examples: (a) Faler, C. A.; Joullié, M. M. Org. Lett. 
2007, 9, 1987. (b) Song, Z. L.; Lu, T.; Hsung, R. P.; Al-Rashid, Z. F.; 
Ko, C. H.; Tang, Y. Angew. Chem. Int. Ed. 2007, 46, 4069. (c) Valenta, 
P.; Carroll, P. J.; Walsh, P. J. J. Am. Chem. Soc. 2010, 132, 14179, and 
references therein.  
(12) (a) Mitsuya, H.; Yarchoan, R.; Broder, S. Science 1990, 249, 
1533. (b) Basavapathruni, A.; Anderson, K. S. The FASEB Journal 
2007, 21, 3795. 
 
It is well-known that nucleosides and their mimetics13 
are widespread as therapeutic agents for the treatment of 
cancer, infections and viral diseases. Therefore the 2-
aminotetrahydrofuran core may be rightly considered as a 
privileged scaffold for drug discovery.  
Herein, we describe the first catalytic method for the 
[3+2] annulation of donor-acceptor aminocyclopropanes 
with aldehydes affording 2-aminotetrahydrofurans with 
excellent diastereoselectivity (Scheme 1). 
Our group has been interested in the use of D-A 
cyclopropanes (D = NPg or aryl, Pg = protecting group) 
as precursors of reactive intermediates in cyclization 
reactions onto electron-rich olefins or heterocycles.14 In 
particular, we made use of aminocyclopropanes as acyl 




Scheme 1. [3+2] annulation of D-A aminocyclopropanes with 
aldehydes. 
 
In 2011, we decided to investigate the use of more 
convergent annulation reactions of aminocyclopropanes 
for the efficient synthesis of carbo- and hetero- cycles. As 
a result of these efforts, we reported the first catalytic, 
enantiospecific [3+2] annulation between silyl enol ethers 
and D-A aminocyclopropane 2a to give 
cyclopentylamines (Eq. 1).15  
 
The fine-tuning of the D-A substituents on 2a was 
required to reach an optimal compromise between 
stability and reactivity. We found that the combination of 
phthalimide as weak donor group and a gem-diester as 
acceptor to be ideal. As an extension to our work, we 
were wondering if phthaloyl aminocyclopropane 2a could 
                                                     
(13) Herdewijn, P., Modified Nucleosides: in Biochemistry, 
Biotechnology and Medicine; Wiley-VCH, Weinheim, 2008. 
(14) (a) De Simone, F.; Andrès, J.; Torosantucci, R.; Waser, J. Org. 
Lett. 2009, 11, 1023. (b) De Simone, F.; Gertsch, J.; Waser, J. Angew. 
Chem., Int. Ed. 2010, 49, 5767.  
(15) De Nanteuil, F.; Waser, J. Angew. Chem. Int. Ed. 2011, 50, 
12075. Aminocyclopropane 2a can be synthesised in multi-grams scale 
via rhodium-catalysed cyclopropanation of commercially available 
vinylphthalimide with diethyl diazomalonate. 
be exploited in the [3+2] reaction with other partners, 
such as carbonyls.  
We decided to examine first the reaction of D-A 
aminocyclopropane 2a with benzaldehyde (3a). In 
contrast to the results obtained with enol ethers, the use of 
tin tetrachloride (Eq. 1) was not ideal, since a low yield 
was observed at rt, while irreproducible results were 
obtained at -78 °C (Table 1, entries 1-2). We 
consequently decided to screen a more extended selection 
of Lewis acids. Pleasingly, all Lewis acids tested, except 
Yb(OTf)3 (entry 3, Table 1), were competent catalysts for 
the activation of aminocyclopropane 2a, affording 2-
amino tetrahydrofuran 4aa in excellent 
diastereoselectivity in favour of the cis isomer (entries 4-
11). Employing In(OTf)3, a trace of the trans isomer 
could be identified in the crude 1H NMR spectrum (dr = 
19:1, entry 4), otherwise only the 2,5-cis 
tetrahydrofuran16 was detected. Cyclopropane 2a was 
completely consumed after 90 minutes in all cases, except 
for Cu(OTf)2 (entry 5).  
 
Table 1. Screening of Lewis Acidsa 
 
 
entry Lewis acid yield (%)b dr (cis:trans)c 
1d SnCl4 46 >20:1 
2 SnCl4 70-100 >20:1 
3 Yb(OTf)3 n.r. - 
4 In(OTf)3 72 19:1 
5e Cu(OTf)2 50
  >20:1 
6 InCl3 74 >20:1 
7 AuCl 91 >20:1 
8 Sn(OTf)2 82 >20:1 
9 Hf(OTf)4 100 >20:1 
10 Sc(OTf)3 100 >20:1 
11 FeCl3-Al2O3 100 >20:1 
a Reaction conditions: 1.0 equiv 2a, 1.5 equiv 3a, 20 mol % of Lewis 
acid, 0.1 M in dichloromethane. b Yield was determined via 1H NMR 
spectroscopy using hexamethyldisiloxane as internal standard. c 
Determined by 1H NMR spectroscopy on the crude raction mixture. d 
Performed at -78 °C. e Only 50% conversion of 2a was observed. 
 
The effect of the counteranion was studied in the case 
of indium salts, and it proved negligible (triflate vs. 
chloride, entry 4 vs. 6). When the formation of 5-
membered ring 4aa was not quantitative (entries 1-2, 4-
8), the crude 1H NMR spectrum showed the presence of 
by-products, most likely derived from decomposition of 
the Lewis acid-activated aminocyclopropane 2a. The 
cleanest reactions were observed with Hf(OTf)4, Sc(OTf)3 
and FeCl3-Al2O3 (entries 9-11).17 We selected the latter as 
                                                     
(16) 2,5-relative stereochemistry was assigned on the basis of x-ray 
diffraction analysis performed on compound 4ab, and extended to the 
other compounds of the serie on the basis of the regularity in their NMR 
spectra (see Figure 3 and supporting information for details). 
(17) Iron trichloride gave comparable results, but the alumina-
supported reagent was preferred because it is easier to handle and 
known to be a scavenger of adventitious traces of water and acid. For 
catalyst to continue our studies due to its low cost and 
toxicity.18 Although the efficiency of iron catalysts in 
promoting cycloaddition and ring expansion reactions is 
well established,19 this represents the first example of 
iron-catalyzed [3+2] annulation of D-A cyclopropanes.  
Next, the scope of the reaction with D-A 
aminocyclopropanes 2a and 2b was explored, using 5 mol 
% of iron(III) chloride on alumina, and 1.5 equiv. of 
aldehydes 3a-o at room temperature (Table 2).  
 




entry R R' yield (%) drb,c(dr)d 
1(4aa) Et Ph (3a) 94 >20:1 
2(4ba) Me Ph (3a) 95 >20:1 
3(4ab) Et 4-MeOC6H4 (3b) 97 6:1 
4(4bc) Me 2-MeOC6H4 (3c) 83 5:1 
5(4bd) Me 2-thienyl (3d) 84 5:1 
6(4ab)e Et 4-MeOC6H4 (3b) 98 9:1(>20:1) 
7(4bc)e Me 2-MeOC6H4 (3c) 92 17:1 (>20:1) 
8(4bd)e Me 2-thienyl (3d) 89 >20:1 
9(4be) Me 4-ClC6H4 (3e) 91 >20:1 
10(4bf) Me 4-NO2C6H4 (3f) 71 >20:1 
11(4bg) Me (E)-CH=CHPh (3g) 94 2.5:1 
12(4bg)e Me (E)-CH=CHPh (3g) 95 10:1(>20:1) 
13(4ah) Et (E)-CH=CHC3H7 (3h) 99 10:1(>20:1) 
14(4bh) Me (E)-CH=CHC3H7 (3h) 95 7:1(>20:1) 
15(4ai) Et n-Pr (3i) 94 9:1(>20:1) 
16(4bl) Me CH2CH2Ph (3l) 89 >20:1 
17(4am) Et i-Pr (3m) 99 7:1 
18(4an) Et Cyclohexyl (3n) 90 7:1 
19(4bo) Me t-Bu (3o) 92 9:1(>20:1) 
a Standard reaction conditions: 0.2 mmol 2a-b, 1.5 equiv 3a-o, 5 mol 
% of FeCl3-Al2O3 , 0.1 M in dichloromethane. 
b Expressed as cis:trans. c 
Determined by 1H NMR spectroscopy on the crude raction mixture. d 
Obtained after one single recrystallization (see Supporting 
Informations). e Reaction run at -10 °C. 
 
In general, excellent yields were obtained in short 
reaction time (2 hours),20 while employing aldehydes with 
diverse steric and electronic properties. No difference in 
reactivity/selectivity was observed between the ethyl 
diester 2a and the methyl diester 2b in the reaction with 
benzaldehyde (3a) (entry 1 vs. 2). The electron-rich para- 
                                                                                      
examples on the use of FeCl3-Al2O3, see: a) Tietze, L. F.; Beifuss, U. 
Synthesis 1988, 5, 359. b) Tietze, L. F.; Beifuss, U.; Antel, J.; Sheldrick, 
G. M. Angew. Chem., Int. Ed. 1988, 27, 703.  
(18) In the last decade, a revival of iron catalysis in organic synthesis 
was observed, due to the abundance and versatility of this 
environmentally benign metal. See for example: Iron Catalysis 
Fundamentals and Applications; Plietker, B., Ed.; Topics in 
Organometallic Chemistry; Springer-Verlag: Berlin Heidelberg, 2011; 
Vol. 33.  
(19) (a) Hilt, G.; Janikowski, J. Iron Catalysis in Organic Chemistry: 
Reactions and Applications, Wiley-VCH, Weinheim, 2008, Chapter 9. 
(b) Bolm, C.; Legros, J.; Le Paih, J.; Zani, L. Chem. Rev 2004, 104, 
6217.  
(20) Two hours was the chosen standard time to have full conversion. 
When completion was reached in shorter time, the prolonged stirring 
with the catalyst at rt caused no erosion in yield or dr. 
and ortho- anisaldehydes (3b-c) and thiophene-2-
carboxaldehyde (3d) displayed modest stereoselectivities 
at rt (up to 6:1 cis:trans; entries 3-5), nevertheless 
increased dr’s were obtained at a lower temperature (up to 
>20:1 cis:trans, entries 6-8). Interestingly, no detrimental 
effect on yield and stereoselectivity of ortho vs. para 
substituent was observed with anisaldehyde 3c vs. 3b 
(entries 6-7). In all cases, the two isomers could not be 
separated by flash chromatography. However, the pure cis 
isomer could be obtained by means of a single 
recrystallization, except for products 4am and 4an. The 
x-ray diffraction analysis performed on 
aminotetrahydrofuran 4ab allowed the unambiguous 




Figure 2. X-ray structure of aminotetrahydrofuran 4ab. 
 
The annulation reaction was not limited to aromatic 
aldehydes, and a good yield was also obtained in the case 
of cinnamyl aldehyde (4bg), albeit with a low 
diastereoselectivity (entry 11). Once again, the cis-
selectivity could be increased by lowering the 
temperature to -10 °C (entry 12). The reaction was also 
successful for unsaturated aldehyde 3h, both with 
aminocyclopropanes 2a and 2b (entries 13 and 14). 
Aliphatic aldehydes are generally challenging substrates 
for Lewis acids-catalyzed reactions, as they are prone to 
undergo aldol side reactions. Gratifyingly, this was not an 
issue under our mild reaction conditions, and aliphatic 
aldehydes with linear (entries 15-16), or branched (entries 
17-19) substituents afforded the corresponding amino 
tetrahydrofurans in outstanding yields (89-99%) and good 
diastereoselectivities (up to >20:1 cis:trans). 
As a further evidence of the efficiency of our 
methodology, the reaction of aminocyclopropane 2a with 
an equimolar amount of benzaldehyde (3a) in the 
presence of 1 mol % loading of iron catalyst, afforded 
compound 4aa in 88% yield and excellent dr on a 1 mmol 
scale (Eq. 2).  
 
To gain more knowledge on the mechanism of our 
[3+2] annulation, enantioenriched 2a (er = 99:1)21 was 
reacted with 3a under the standard reaction conditions 
(Eq. 3). We had found in our previous work that the 
reaction of enantiopure aminocyclopropane 2a with silyl 
enol ethers was enantiospecific with all the olefins 
tested,15 indicating most probably the formation of a tight, 
configurationally stable ion pair between the 
cyclopropane and the tin catalyst. In contrast, the iron-
catalysed annulation of 2a with benzaldehyde (3a) at rt 
resulted in a complete loss of the stereochemical 
information, as tetrahydrofuran 4aa was isolated in a 
racemic form.8b,22 This evidence suggests that, upon 
Lewis acid activation, the aminocyclopropane undergoes 
fast racemization via an open, zwitterionic species. While 
the result hampers the synthesis of enantioenriched amino 
THFs, it is a potential starting point for the development 
of a dynamic kinetic asymmetric transformation 
(DyKAT).8c,23  
 
In summary, we have developed the first iron (III) 
catalysed [3+2] annulation of aminocyclopropanes with 
aldehydes, affording aminotetrahydrofurans in excellent 
yields (71-99%) and diasteroselectivities (up to >20:1 dr). 
This protocol represents an atom-economic, 
stereoselective route to unprecedented structures, that 
share a aminotetrahydrofuran motif of utmost value, due 
to its presence in DNA and RNA. The exploration of the 
synthetic potential of the aminotetrahydrofurans,24 the 
development of an asymmetric version of the reaction, as 
well as its extension to ketones are currently under 
investigation in our laboratories. 
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(21) Obtained by preparative HPLC separation on chiral stationary 
phase (see supporting information for details).  
(22) Sapeta, K.; Kerr, M. A. J. Org. Chem 2007, 72, 8597. 
(23) (a) Pellissier, H. Chirality from dynamic kinetic resolution; RSC 
Publishing: Cambridge, 2011. (b) Steinreiber, J. ; Faber, K.; Griengl, H. 
Chem. Eur. J. 2008, 14, 8060. 
(24) The ring opening of phthalimide with amines was accomplished, 
but the cleavage of the second C-N bond could not yet be achieved due 
to the instability of the resulting free aminotetrahydrofuran. As 
alternative strategies, the use of modified aminocyclopropanes or the 
substitution of the phthalimide with nucleophiles will be investigated in 
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1 Experimental procedures  
1.1 General Methods 
 
All reactions were carried out in oven dried glassware under an atmosphere of nitrogen, 
unless stated otherwise. For quantitative flash chromatography technical grade solvents were 
used. For flash chromatography for analysis, HPLC grade solvents from Sigma-Aldrich were 
used. CH2Cl2 was dried by passage over activated alumina under nitrogen atmosphere (H2O 
content < 30 ppm, Karl-Fischer titration). All chemicals were purchased from Acros, Aldrich, 
Fluka, VWR, Aplichem or Merck and used as such unless stated otherwise. Chromatographic 
purification was performed as flash chromatography using Macherey-Nagel silica 40-63, 60 
Å, using the solvents indicated as eluent with 0.1-0.5 bar pressure. TLC was performed on 
Merck silica gel 60 F254 TLC plastic plates and visualized with UV light, permanganate 
stain, CAN stain or Anisaldehyde stain. Melting points were measured on a calibrated Büchi 
B-540 melting point apparatus using open glass capillaries. 1H-NMR spectra were recorded 
on a Brucker DPX-400 400 MHz spectrometer in chloroform-d, all signals are reported in 
ppm with the internal chloroform signal at 7.26 ppm as standard. The data is being reported as 
(s = singlet, d = doublet, t = triplet, q = quadruplet, qi = quintet, m = multiplet or unresolved, 
br = broad signal, coupling constant(s) in Hz, integration; interpretation). 13C-NMR spectra 
were recorded with 1H-decoupling on a Brucker DPX-400 100 MHz spectrometer in 
chloroform-d, all signals are reported in ppm with the internal chloroform signal at 77.0 ppm 
as standard. Infrared spectra were recorded on a JASCO FT-IR B4100 spectrophotometer 
with an ATR PRO410-S and a ZnSe prisma and are reported as cm-1 (w = weak, m = medium, 
s = strong, sh = shoulder). Gas chromatographic and low resolution mass spectrometric 
measurements were performed on a Perkin-Elmer Clarus 600 gas chromatographer and mass 
spectrometer using a Perkin-Elmer Elite fused silica column (length: 30 m, diameter: 0.32 
mm) and Helium as carrier gas. High resolution mass spectrometric measurements were 
performed by the mass spectrometry service of ISIC at the EPFL on a MICROMASS (ESI) 
Q-TOF Ultima API. HPLC measurement were done on a JASCO HPLC system with an 
AS2055 Autosampler, a PU 2089 Pump, a UV 2075 detector and a SEDEX 85 (SEDERE) 
detector using a CHIRALPAK IC, IB or IA column from DAICEL Chemical Industries Ltd. 
HPLC grade solvents from Sigma-Aldrich were used. The aldehydes used in this study are all 





commercially available and were used as received. Iron trichloride on alumina was prepared 
according to a reported procedure.1 
1.2 Preparation of amino cyclopropanes 2a-b 
 
Diethyl 2-(1,3-dioxoisoindolin-2-yl)cyclopropane-1,1-dicarboxylate (2a) 
Following a reported procedure2, a two-neck flask equipped with a nitrogen inlet was loaded 
with 14 mg (0.018 mmol, 0.1 mol %) of bis[rhodium(''-tetramethyl-1,3-
benzenedipropionic acid)] inside the glove box, then the flask was sealed with a rubber 
septum and evacuated from the glove box. A solution of N-vinyl-phthalimide (3.0 g, 18 
mmol, 1 eq) in 30 mL of dry dichloromethane was added to the flask and the resulting green 
suspension was cooled down to 0°C with an ice/water bath. A solution of diethyl-2-
diazomalonate3 (4.0 g, 21 mmol, 1.2 eq) in 20 mL of dichloromethane was added over five 
minutes. When the addition was complete, the reaction was allowed to warm to room 
temperature. After 5 h at room temperature, the solvent was removed under reduced pressure 
and the crude was directly purified by column chromatography (SiO2, 9/1 to 7/3 (n-hexane: 
AcOEt). 5.4 g (16 mmol, 90 % yield) of 2a as a colorless solid were obtained.  
Rf 0.36 (n-hex/EtOAc 6/4); 
Mp 93 °C; 
1H NMR (400 MHz, CDCl3)  7.85 (m, 2 H, Phth), 7.74 (m, 2 H, Phth), 
4.30 (m, 2 H, OCH2), 4.07 (m, 2 H, OCH2), 3.71 (dd, 1 H, J = 8.5, 6.6 Hz, 
N-C-H), 2.74 (t, 1 H, J = 6.5 Hz, CH2), 2.02 (dd, 1 H, J = 8.5, 6.4 Hz, CH2), 1.34 (t, 3 H, J = 
7.1 Hz, CH3), 1.12 (t, 3 H, J = 7.1 Hz, CH3); 
13C NMR (101 MHz, CDCl3)  168.2, 167.8, 166.4, 134.3, 131.6, 123.4, 62.0, 61.8, 34.7, 
33.5, 19.2, 14.1, 13.8; 
IR 2985 (w), 2938 (w), 2907 (w), 1783 (m), 1719 (s), 1614 (w), 1393 (s), 1321 (m), 1218 (s), 
1133 (m), 719 (s); 
HRMS (ESI) calcd for C17H18NO6
+ [M+H]+ 332.1129; found 332.1135. 
HPLC analysis: Chiracel IA (0.46 x 25 cm): 85:15 (hexane: i-PrOH), flow 1.0mL/min. t1: 9.0 
min, t2: 11.2 min. 
                                                 
[1] Tietze, L. F.; Beifuss, U. Synthesis 1988, 5, 359.  
[2] De Nanteuil, F.; Waser, J. Angew. Chem., Int. Ed. 2011, doi: 10.1002/anie.201106255. 
[3] P. Wyatt, A. Hudson, J. Charmant, A. G. Orpen, H. Phetmung, Org. Biomol. Chem. 2006, 4, 2218 





Preparative HPLC: Chiracel IA (20 x 250 mm), 85:13.5:1.5 (hexane: AcOEt: i-PrOH), flow 
10 mL/min. t1 = 18 min,  
25
D
  115 (er: 98:2, c 1.0, CHCl3), t2 = 24 min,  
25
D
  -115 (er: 98:2, 
c 1.0, CHCl3). 
Dimethyl 2-(1,3-dioxoisoindolin-2-yl)cyclopropane-1,1-dicarboxylate (2b) 
Following the same procedure described above, using 2.5 g (14 mmol, 1 eq) of N-vinyl-
phthalimide, 2.5 g (15 mmol, 1.1 eq) of dimethyl-2-diazomalonate and 10.9 mg (0.014 mmol, 
0.1 mol %) of bis[rhodium(''-tetramethyl-1,3-benzenedipropionic acid)], 3.40 g (11.2 
mmol, 78 % yield) of 2b were isolated as a colorless solid. 
Rf 0.27 (n-hex/EtOAc 6/4); 
Mp 124-125 °C; 
1H NMR (400 MHz, CDCl3) 7.86 (m, 2 H, Phth), 7.75 (m, 2 H, Phth), 
3.85 (s, 3 H, OMe), 3.72 (dd, 1 H, J = 8.5, 6.6 Hz, N-CH), 3.64 (s, 3 H, 
OMe), 2.73 (dd, 1 H, J = 6.5, 6.5 Hz, CH2), 2.06 (dd, 1H, J = 8.5, 6.4 Hz, CH2); 
13C NMR (101 MHz, CDCl3)  168.5, 167.8, 166.9, 134.3, 131.4, 123.5, 53.1, 53.0, 34.9, 
33.1, 19.6; 
IR 2956 (w), 1783 (w), 1727 (s), 1468 (w), 1439 (w), 1399 (m), 1329 (m), 1294 (m), 1222 
(m), 1134 (w), 909 (w), 876 (w), 720 (m); 
HRMS (ESI) calcd for C15H14NO6
+ [M+H]+ 304.0816; found 304.0804. 
1.3 Standard procedure for the screening of Lewis acids 
 
All the reactions were carried out under nitrogen in glass vials equipped with rubber septa and 
Teflon-coated stir bars. The Lewis acid (4 mol, 20 mol %) was added to the vial in the glove 
box, followed by a solution of aminocyclopropane 2a (20 mol, 6.6 mg, 1 equiv.) and 
benzaldehyde 3a (30mol, 3 L, 1.5 equiv.) in anhydrous dichloromethane (0.1 M, 0.2 mL) 
was added under nitrogen. The mixture was stirred for 90 min at the indicated temperature, 
and then it was diluted with dichloromethane (0.5 mL) and flushed through a short plug of 
silica gel. The solvent was removed in vacuo, then a 1H-NMR sample was prepared by 
dissolving the crude mixture in CDCl3 (0.7 mL) and a standard hexamethyldisiloxane solution 
(0.01 M, 0.111 mL) was added. The 1H-NMR yield was calculated according to the following 
calibration curve.  
 





1H-NMR calibration curve 
Hexamethyldisiloxane (4.3 L, 0.02 mmol) was dissolved in CDCl3 (2.0 mL), to give a 0.01 
M standard solution. Compound 4aa (11.8 mg, 0.03 mmol) was dissolved in CDCl3 (0.7 mL), 
then the following volumes of standard 0.01 M solution were added: 150 L for sample A 
(1.50 mol); 188 L for sample B (1.88 mol); 250 L for sample C (2.50 mol); 375 L for 
sample D (3.75 mol) ; 750 L for sample E (7.50 mol) . 
1H NMR spectra were acquired for solution A-E, and the ratios between the integrals of the 
signal at δ 6.00 (dd, 1 H, J = 11.0, 5.2 Hz, CHNPhth) of 4aa and the signal at  0.06 (s, 1 H, 
TMS) of hexamethyldisiloxane were determined. These experimental ratios were plotted vs. 
the ratios mmol 4aa / mmol hexamethyldisiloxane to give the calibration graph.  
 
1.4 Standard procedure for the iron-catalysed [3+2] annulation of 
amino cyclopropanes with aldehydes 
A two-neck flask equipped with a nitrogen inlet was loaded with FeCl3-Al2O3 (10 mol, 10 
mg, 5 mol %) inside the glove box, then the flask was sealed with a rubber septum and 
evacuated from the glove box. The iron catalyst was stirred in 1 mL of anhydrous 
dichloromethane, before adding a solution of aminocyclopropane 2a-b (0.20 mmol, 60-66 
mg, 1 equiv.) and aldehyde 3a-o (1.5 equiv.) in anhydrous dichloromethane (1 mL). The 
mixture was stirred under nitrogen for 2 h at rt (or -10° C for 4ab, 4bc, 4bd and 4bg), then it 
was diluted with dichloromethane (2 mL) and flushed through a short plug of silica gel, 
eluting with EtOAc (5 mL). The solvent was removed in vacuo, affording the crude reaction 
mixture, which was submitted to 1H NMR analysis to determine the dr before purification via 
flash chromatography (SiO2, 8/2 to 1/1 (n-hexane: AcOEt)). 





































2 Scope of the reaction 
Diethyl dihydro-5-(1,3-dioxoisoindolin-2-yl)-2-phenylfuran-3,3(2H)-dicarboxylate (4aa) 
Flash chromatography afforded the title compound (82 mg, 0.19 mmol, 94% yield) as a 
colorless solid, as a single diastereoisomer (dr > 20:1).  
When the reaction was performed on 1 mmol scale of 2a (331 mg), with 1 eq. of 
benzaldehyde (102 L, 1 mmol) and 1 mol % of FeCl3-Al2O3 (10 mg, 10 mol), 385 mg of 
product 4aa (0.88 mmol, 88 % yield) were obtained. 
Rf 0.58 (n-hex/EtOAc 6/4);  
Mp 103-105 °C; 
1H NMR (400 MHz, CDCl3) δ 7.94 (dd, 2 H, J = 5.5, 3.1 Hz, Phth), 
7.79 (dd, 2 H, J = 5.5, 3.1 Hz, Phth), 7.58 (d, 2 H, J = 7.0 Hz, Ph), 
7.37-7.23 (m, 3 H), 6.00 (dd, 1 H, J = 11.0, 5.2 Hz, CHNPhth), 5.84 (s, 1 H, CHPh), 4.45-
4.22 (m, 3 H, OCH2CH3 + CH2CHNPhth), 3.78-3.67 (m, 1 H, OCH2CH3), 3.54-3.43 (m, 1 H, 
OCH2CH3), 2.52 (dd, 1 H, J = 13.2, 5.2 Hz, CH2CHNPhth), 1.33 (t, 3 H, J = 7.1 Hz, 
OCH2CH3), 0.84 (t, 3 H, J = 7.1 Hz, OCH2CH3);  
13C NMR (101 MHz, CDCl3) δ 170.6, 167.4, 137.8, 134.5, 131.8, 128.4, 128.0, 127.8, 123.8, 
82.3, 79.1, 65.0, 62.4, 61.7, 34.2, 14.0, 13.4;  
IR 2983 (w), 2934 (w), 1783 (w), 1725 (s), 1469 (w), 1380 (m), 1370 (m), 1338 (w), 1297 
(w), 1266 (m), 1233 (w), 1205 (w), 1194 (w), 1140 (m), 1113 (w), 1078 (w), 1026 (w), 916 
(w), 868 (w), 757 (w), 721 (m), 703 (w), 658 (w);  
HRMS (ESI) calcd for C24H24NO7
+ [M+H]+ 438.1547; found 438.1547.  
HPLC analysis: Chiracel IA: 85:15 (hexane: i-PrOH), flow 1.0 mL/min. t1:13.5 min; t2: 24.0 
min 
 
Dimethyl 5-(1,3-dioxoisoindolin-2-yl)-2-phenyldihydrofuran-3,3(2H)-dicarboxylate (4ba) 
Flash chromatography afforded the title compound (78 mg, 0.19 mmol, 95% yield) as a 
colorless solid, as a single diastereoisomer (dr > 20:1).  
Rf 0.52 (n-hex/EtOAc 6/4);  
Mp 170-173 °C; 
1H NMR (400 MHz, CDCl3) δ 7.94 (dd, 2 H, J = 5.5, 2.9 Hz, Phth), 
7.79 (dd, 2 H, J = 5.5, 2.9 Hz, Phth), 7.57 (d, 2 H, J = 7.2 Hz, Ph), 7.38-7.20 (m, 3 H, Ph), 
5.99 (dd, 1 H, J = 11.0, 5.2 Hz, CHNPhth), 5.85 (s, 1 H, CHPh), 4.28 (dd, 1 H, J = 13.2, 11.0 





Hz, CH2CHNPhth), 3.88 (s, 3 H, OCH3), 3.15 (s, 3 H, OCH3), 2.53 (dd, 1 H, J = 13.2, 5.2 Hz, 
CH2CHNPhth);  
13C NMR (101 MHz, CDCl3) δ 170.9, 167.8, 167.2, 137.5, 134.5, 131.6, 128.3, 127.8, 127.4, 
123.7, 82.3, 79.1, 65.0, 53.4, 52.3, 34.0; 
IR 3067 (w), 3034 (w), 3010 (w), 2954 (w), 1781 (m), 1781 (m), 1720 (s), 1612 (w), 1498 
(w), 1469 (w), 1457 (w), 1436 (m), 1365 (m), 1338 (m), 1272 (s), 1233 (m), 1208 (m), 1137 
(s), 1116 (m), 1077 (m), 1054 (m), 1022 (m), 973 (m), 914 (m), 870 (m), 756 (m), 721 (s), 
703 (s), 659 (m);  
HRMS (ESI) calcd for C22H20NO7




Flash chromatography afforded the title compound (90 mg, 0.19 mmol, 97% yield) as a 
colorless solid, as an inseparable mixture of diastereoisomers; dr = 6:1 determined by 
integration of 1H NMR signals: δminor 6.53 (dd), δmajor 5.96 ppm (dd).  
When the reaction was performed at -10 °C, 91 mg (0.195 mmol, 98% yield) of the title 
compound were isolated (dr = 9:1). Recrystallization from iPrOH afforded analytically pure 
cis isomer (dr > 20:1). 
Rf 0.79 (n-hex/EtOAc 6/4);  
Mp 122-124 °C; 
 1H NMR (400 MHz, CDCl3) δ 7.92 (dd, 2 H, J = 5.5, 3.1 Hz, 
Phth), 7.77 (dd, 2 H, J = 5.5, 2.9 Hz, Phth), 7.52 (d, 2 H, J = 8.8 
Hz, Ar), 6.87 (d, 2 H, J = 8.8 Hz, Ar), 5.96 (dd, 1 H, J = 11.1, 5.1 Hz CHNPhth), 5.81 (s, 1 H, 
CHO), 4.43-4.21 (m, 3 H, OCH2CH3 + CH2CHNPhth), 3.79 (s, 3H, OCH3), 3.82-3.71 (m, 1 
H, OCH2CH3), 3.61-3.49 (m, 1 H, OCH2CH3), 2.49 (dd, 1 H, J = 13.2, 5.1 Hz, 
CH2CHNPhth), 1.31 (t, 3 H, J = 7.1 Hz, OCH2CH3), 0.88 (t, 3 H, J = 7.1 Hz, OCH2CH3);  
13C NMR (101 MHz, CDCl3) δ 170.6, 167.6, 167.4, 159.7, 134.4, 131.8, 130.0, 129.1, 123.7, 
113.3, 82.0, 79.0, 64.9, 62.3, 61.7, 55.3, 34.1, 14.1, 13.5;  
IR 2982 (w), 2938 (w), 1782 (w), 1722 (s), 1615 (w), 1516 (m), 1468 (w), 1369 (m), 1338 
(w), 1299 (w), 1266 (m), 1251 (m), 1233 (w), 1206 (w), 1193 (w), 1179 (w), 1138 (m), 1112 
(w), 1077 (w), 1054 (m), 1027 (m), 914 (w), 867 (w), 847 (w), 843 (w), 721 (m), 706 (w), 
653 (w); 
HRMS (ESI) calcd for C25H26NO8
+ [M+H]+ 468.1653; found 468.1670. 
 






dicarboxylate (4bc)  
Flash chromatography afforded the title compound (73 mg, 0.17 mmol, 83% yield) as a 
colorless solid, as an inseparable mixture of diastereoisomers; dr = 5:1 determined by 
integration of 1H NMR signals: δminor 6.46-6.53 (m), δmajor 6.02 ppm (dd).  
When the reaction was performed at -10 °C, 81 mg (0.18 mmol, 92% yield) of the title 
compound were isolated (dr = 17:1). Recrystallization from iPrOH afforded analytically pure 
cis isomer (dr > 20:1). 
Rf 0.34 (n-hex/EtOAc 6/4);  
Mp 168-170 °C; 
1H NMR (400 MHz, CDCl3) δ 7.91 (dd, 2 H, J = 5.5, 3.1 Hz, Phth), 
7.80-7.69 (m, 3 H, Phth + Ar), 7.24 (t, 1 H, J = 8.2 Hz, Ar), 6.99 (t, 1 
H, J = 7.5 Hz, Ar), 6.82 (d, 1 H, J = 8.2 Hz, Ar), 6.29 (s, 1 H, CHO), 6.02 (dd, 1 H, J = 10.6, 
5.3 Hz, CHNPhth), 4.23 (dd, 1 H, J = 13.1, 10.6 Hz, CH2CHNPhth), 3.87 (s, 3H, OCH3), 3.82 
(s, 3H, OCH3), 3.20 (s, 3H, OCH3), 2.49 (dd, 1 H, J = 13.1, 5.3 Hz, CH2CHNPhth); 
13C NMR (101 MHz, CDCl3) δ 166.9, 164.2, 163.4, 153.3, 131.9, 129.3, 126.9, 126.1, 124.1, 
121.6, 118.6, 108.4, 78.7, 76.5, 64.7, 56.5, 54.2, 53.2, 36.9;  
IR 3013 (w), 2951 (w), 2838 (w), 1780 (w), 1732 (s), 1718 (s), 1603 (w), 1495 (w), 1462 (w), 
1435 (w), 1376 (s), 1270 (s), 1199 (m), 1137 (s), 1072 (m), 1052 (s), 1021 (s), 974 (m), 944 
(w), 891 (w), 871 (m), 761 (m), 721 (s), 656 (m);  
HRMS (ESI) calcd for C23H22NO8




Flash chromatography afforded the title compound (70 mg, 0.17 mmol, 84% yield) as a 
colorless solid, as an inseparable mixture of diastereoisomers; dr = 5:1 determined by 
integration of 1H NMR signals: δminor 6.52 (dd), δmajor 5.94 ppm (dd).  
When the reaction was performed at -10 °C, 74 mg (0.18 mmol, 89% yield) of the title 
compound were isolated (dr > 20:1). 
Rf 0.44 (n-hex/EtOAc 6/4);  
Mp 188-190 °C; 
1H NMR (400 MHz, CDCl3) δ 7.92 (dd, 2 H, J = 5.5, 3.0 Hz, Phth), 
7.79 (dd, 2 H, J = 5.5, 3.0 Hz, Phth), 7.30-7.24 (m, 2 H, thiophene), 





6.99 (dd, 1 H, J = 5.0, 3.6 Hz, thiophene), 6.10 (s, 1 H, CHO), 5.94 (dd, 1 H, J = 11.1, 5.0 Hz, 
CHNPhth), 4.33 (dd, 1 H, J = 13.2, 11.1 Hz, CH2CHNPhth), 3.89 (s, 3 H, OCH3), 3.38 (s, 3 
H, OCH3), 2.53 (dd, 1 H, J = 13.2, 5.0 Hz, CH2CHNPhth);  
13C NMR (101 MHz, CDCl3) δ 170.5, 167.4, 167.2, 140.3, 134.5, 131.6, 126.8, 126.6, 125.8, 
123.7, 79.0, 78.3, 65.2, 53.5, 52.6, 33.1;  
IR 2954 (w), 1782 (w), 1722 (s), 1436 (w), 1371 (s), 1278 (m), 1244 (m), 1202 (w), 1136 
(m), 1076 (w), 1039 (w), 1019 (m), 973 (w), 914 (w), 884 (w), 869 (w), 798 (w), 721 (m); 
HRMS (ESI) calcd for C20H18NO7S





Flash chromatography afforded the title compound (81 mg, 0.18 mmol, 91% yield) as a 
colorless solid, as a single diastereoisomer (dr > 20:1).  
Rf 0.50 (n-hex/EtOAc 6/4);  
Mp 173-175 °C; 
1H NMR (400 MHz, CDCl3) δ 7.93 (dd, 2 H, J = 5.5, 3.1 Hz, 
Phth), 7.79 (dd, 2 H, J = 5.5, 3.1 Hz, Phth), 7.52 (d, 2 H, J = 8.5 
Hz, Ar), 7.32 (d, 2 H, J = 8.5 Hz, Ar), 5.97 (dd, 1 H, J = 10.9, 5.2 Hz, CHNPhth), 5.81 (s, 1 
H, CHO), 4.22 (dd, 1 H, J = 13.3, 10.9 Hz, CH2CHNPhth), 3.88 (s, 3 H, OCH3), 3.22 (s, 3 H, 
OCH3), 2.53 (dd, 1 H, J = 13.3, 5.2 Hz, CH2CHNPhth);  
13C NMR (101 MHz, CDCl3) δ 170.8, 167.7, 167.3, 136.2, 134.6, 134.3, 131.7, 129.0, 128.2, 
123.8, 81.7, 79.2, 65.0, 53.6, 52.6, 34.0;  
IR 2954 (w), 1783 (m), 1734 (s), 1721 (s), 1612 (w), 1598 (w), 1491 (w), 1470 (w), 1436 (w), 
1436 (w), 1377 (s), 1274 (m), 1234 (m), 1234 (m), 1208 (m), 1208 (m), 1138 (m), 1118 (w), 
1107 (w), 1077 (m), 1056 (m), 1056 (m), 1026 (m), 1015 (m), 973 (w), 913 (w), 913 (w), 870 
(w), 844 (w), 798 (w), 722 (s), 661 (w), 653 (w);  
HRMS (ESI) calcd for C22ClH19NO7




Flash chromatography afforded the title compound (65 mg, 0.14 mmol, 71% yield) as a 
colorless solid, as a single diastereoisomer (dr > 20:1).  





Rf 0.36 (n-hex/EtOAc 6/4);  
Mp 178-181 °C; 
1H NMR (400 MHz, CDCl3) δ 8.21 (d, 2 H, J = 8.8 Hz, Ar), 
7.95 (dd, 2 H, J = 5.5, 3.1 Hz, Phth), 7.82 (dd, 2 H, J = 5.5, 3.1 
Hz, Phth), 7.78 (d, 2 H, J = 8.8 Hz, Ar), 6.02 (dd, 1 H, J = 10.8, 5.4 Hz, CHNPhth), 5.91 (s, 1 
H, CHO), 4.20 (dd, 1 H, J = 13.4, 10.8 Hz, CH2CHNPhth), 3.90 (s, 3 H, OCH3), 3.23 (s, 3 H, 
OCH3), 2.60 (dd, 1 H, J = 13.4, 5.4 Hz, CH2CHNPhth);  
13C NMR (101 MHz, CDCl3) δ 170.5, 167.5, 167.3, 147.9, 145.0, 134.7, 131.6, 128.6, 123.9, 
123.1, 81.3, 79.4, 65.1, 53.7, 52.6, 34.2;  
IR 2955 (w), 1782 (m), 1736 (s), 1609 (w), 1524 (m), 1471 (w), 1458 (w), 1436 (w), 1377 
(s), 1351 (m), 1276 (m), 1247 (w), 1234 (w), 1209 (w), 1139 (m), 1112 (w), 1075 (m), 1058 
(w), 1028 (w), 974 (w), 913 (m), 893 (w), 869 (m), 724 (s), 700 (w), 686 (w), 673 (m), 667 
(w), 652 (w), 639 (w), 631 (w), 614 (w), 604 (w);  
HRMS (ESI) calcd for C22H19N2O9




Flash chromatography afforded the title compound (82 mg, 0.19 mmol, 94% yield) as a 
colorless solid, as an inseparable mixture of diastereoisomers; dr = 2.5:1 determined by 
integration of 1H NMR signals: δminor 6.43 (dd), δmajor 6.02 ppm (dd). 
When the reaction was performed at -10 °C, 83 mg (0.19 mmol, 95% yield) of the title 
compound were isolated (dr = 10:1). Recrystallization from iPrOH afforded analytically pure 
cis isomer (dr > 20:1).  
Rf 0.47 (n-hex/EtOAc 6/4);  
Mp 188-190 °C; 
1H NMR (400 MHz, CDCl3) δ 7.91 (dd, 2 H, J = 5.5, 3.0 Hz, Phth), 
7.77 (dd, 2 H, J = 5.5, 3.0 Hz, Phth), 7.44 (d, 2 H, J = 8.6 Hz, Ph), 
7.36-7.23 (m, 3 H, Ph), 6.67-6.64 (m, 2 H, CH=CH), 6.02 (dd, 1 H, J = 10.3, 5.9 Hz, 
CHNPhth), 5.31 (dd, 1 H, J = 4.7, 3.6 Hz, CHO), 4.09 (dd, 1 H, J = 13.4, 10.3 Hz, 
CH2CHNPhth), 3.90 (s, 3 H, OCH3), 3.66 (s, 3 H, OCH3), 2.64 (dd, 1 H, J = 13.4, 5.9 Hz, 
CH2CHNPhth);  
13C NMR (101 MHz, CDCl3) δ 170.2, 167.4, 167.3, 136.3, 134.5, 134.4, 131.7, 128.6, 128.1, 
126.9, 125.4, 123.7, 82.8, 79.6, 64.9, 53.6, 53.1, 33.0;  





IR 3028 (w), 2955 (w), 1781 (w), 1718 (s), 1451 (w), 1436 (m), 1371 (m), 1355 (m), 1333 
(m), 1273 (s), 1227 (m), 1208 (m), 1133 (m), 1110 (m), 1090 (m), 1075 (m), 1041 (m), 1018 
(m), 1007 (m), 969 (m), 910 (m), 893 (w), 864 (m), 720 (s), 695 (m), 651 (m);  
HRMS (ESI) calcd for C24H22NO7
+ [M+H]+ 436.1391; found 436.1370. 
Diethyl 5-(1,3-dioxoisoindolin-2-yl)-2-((E)-pent-1-en-1-yl)dihydrofuran-3,3(2H)-
dicarboxylate (4ah) 
Flash chromatography afforded the title compound (86 mg, 0.20 mmol, 99% yield) as a sticky 
wax, as an inseparable mixture of diastereoisomers; dr = 10:1 determined by integration of 1H 
NMR signals: δminor 6.45 (dd), δmajor 5.11 ppm (d).  
Recrystallization from iPrOH afforded analytically pure cis isomer (dr > 20:1). 
Rf 0.63 (n-hex/EtOAc 6/4);  
Mp 118-120 °C; 
1H NMR (400 MHz, CDCl3) δ 7.88 (dd, 2 H, J = 5.5, 3.1 Hz, 
Phth), 7.75 (dd, 2 H, J = 5.5, 3.1 Hz, Phth), 5.96-5.74 (m, 3 H, 
CH=CH + CHNPhth), 5.11 (d, 1 H, J = 8.9, Hz, CHO), 4.41-4.08 (m, 4 H, OCH2CH3), 4.00 
(dd, 1 H, J = 13.3, 10.5 Hz, CH2CHNPhth), 2.53 (dd, 1 H, J = 13.3, 5.8 Hz, CH2CHNPhth), 
2.09-1.95 (m, 2 H, CH2CH=CH), 1.46-1.35 (m, 2 H, CH2CH2CH3), 1.32 (t, 3 H, J = 7.1 Hz, 
OCH2CH3), 1.25 (t, 3 H, J = 7.1 Hz, OCH2CH3), 0.90 (t, 3 H, J = 7.3 Hz, CH2CH2CH3);  
13C NMR (101 MHz, CDCl3) δ 169.9, 167.4, 167.0, 136.8, 134.4, 131.8, 126.2, 123.5, 82.7, 
79.2, 64.4, 62.3, 61.8, 34.3, 32.9, 22.1, 14.0, 13.7;4  
IR 2963 (w), 2934 (w), 2874 (w), 1783 (w), 1723 (s), 1467 (w), 1368 (s), 1298 (m), 1263 (s), 
1230 (m), 1206 (m), 1126 (m), 1097 (m), 1042 (m), 1021 (m), 992 (m), 975 (m), 928 (w), 919 
(w), 720 (s), 673 (w), 672 (w);  
HRMS (ESI) calcd for C23H28NO7
+ [M+H]+ 430.1860; found 430.1861.  
Dimethyl 5-(1,3-dioxoisoindolin-2-yl)-2-((E)-pent-1-en-1-yl)dihydrofuran-3,3(2H)-
dicarboxylate (4bh) 
Flash chromatography afforded the title compound (76 mg, 0.19 mmol, 95% yield) as a 
colorless solid, as an inseparable mixture of diastereoisomers; dr = 7:1 determined by 
integration of 1H NMR signals: δminor 6.32 (dd), δmajor 5.10 ppm (d).  
Recrystallization from iPrOH afforded analytically pure cis isomer (dr > 20:1). 
Rf 0.50 (n-hex/EtOAc 6/4);  
                                                 
[4] Two methyl carbons are overlapping. 





Mp 160-161 °C; 
1H NMR (400 MHz, CDCl3) δ 7.87 (dd, 2 H, J = 5.5, 3.1 Hz, 
Phth), 7.75 (dd, 2 H, J = 5.5, 3.1 Hz, Phth), 5.95-5.74 (m, 3 H, 
CH=CH + CHNPhth), 5.10 (d, 1 H, J = 8.8, Hz, CHO), 4.00 (dd, 
1 H, J = 13.3, 10.4 Hz, CH2CHNPhth), 3.86 (s, 3 H, OCH3), 3.72 (s, 3 H, OCH3), 2.55 (dd, 1 
H, J = 13.3, 5.8 Hz, CH2CHNPhth), 2.10-1.95 (m, 2 H, CH2CH=CH), 1.46-1.30 (m, 2 H, 
CH2CH2CH3), 0.89 (t, 3 H, J = 7.3 Hz, CH2CH2CH3);  
13C NMR (101 MHz, CDCl3) δ 170.3, 167.5, 167.4, 137.0, 134.4, 131.7, 126.1, 123.6, 82.8, 
79.3, 64.5, 53.4, 52.8, 34.3, 32.9, 22.2, 13.7;  
IR 2957 (w), 2932 (w), 2872 (w), 1777 (w), 1733 (s), 1712 (s), 1463 (w), 1454 (w), 1435 (w), 
1376 (m), 1363 (m), 1343 (w), 1268 (s), 1233 (m), 1208 (m), 1129 (m), 1103 (m), 1078 (m), 
1057 (w), 1040 (m), 1017 (m), 1006 (m), 975 (m), 962 (m), 908 (m), 879 (m), 863 (m), 802 
(w), 723 (s), 707 (m), 687 (w), 658 (w);  
HRMS (ESI) calcd for C21H24NO7
+ [M+H]+ 402.1547; found 402.1540. 
Diethyl 5-(1,3-dioxoisoindolin-2-yl)-2-propyldihydrofuran-3,3(2H)-dicarboxylate (4ai) 
Flash chromatography afforded the title compound (81 mg, 0.19 mmol, 94% yield) as a sticky 
wax, as an inseparable mixture of diastereoisomers; dr = 9:1 determined by integration of 1H 
NMR signals: δminor 6.29 (dd), δmajor 5.91 ppm (dd).  
Recrystallization from iPrOH afforded analytically pure cis isomer (dr > 20:1). 
Rf 0.63 (n-hex/EtOAc 6/4);  
Mp 82-85 °C; 
1H NMR (400 MHz, CDCl3) δ 7.90 (dd, 2 H, J = 5.6, 3.2 Hz, Phth), 
7.77 (dd, 2 H, J = 5.6, 3.2 Hz, Phth), 5.91 (dd, 1 H, J = 10.2, 6.0 Hz, 
CHNPhth), 4.66 (dd, 1 H, J = 10.8, 2.3 Hz, CHO), 4.40-4.20 (m, 4 H, OCH2CH3), 3.89 (dd, 1 
H, J = 13.4, 10.2 Hz, CH2CHNPhth), 2.55 (dd, 1 H, J = 13.4, 6.0 Hz, CH2CHNPhth), 2.03-
1.91 (m, 1 H, n-Pr), 1.58-1.37 (m, 3 H, n-Pr), 1.34 (t, 3 H, J = 7.0 Hz, OCH2CH3), 1.33 (t, 3 
H, J = 7.3 Hz, CH2CH2CH3), 0.94 (t, 3 H, J = 7.0 Hz, OCH2CH3);  
13C NMR (101 MHz, CDCl3) δ 170.2, 167.9, 167.3, 134.4, 131.9, 123.6, 80.8, 78.9, 63.6, 
62.2, 61.9, 33.6, 33.3, 19.3, 14.0, 13.8;5 
IR 2963 (w), 2938 (w), 2874 (w), 1781 (w), 1721 (s), 1469 (w), 1369 (m), 1296 (m), 1263 
(s), 1228 (m), 1192 (m), 1145 (m), 1120 (m), 1092 (m), 1070 (m), 1037 (m), 1017 (m), 876 
(w), 862 (w), 720 (s), 677 (w), 656 (w);  
                                                 
[5] Two methyl carbons are overlapping. 





HRMS (ESI) calcd for C21H26NO7
+ [M+H]+ 404.1704; found: 404.1713.  
Dimethyl 5-(1,3-dioxoisoindolin-2-yl)-2-phenethyldihydrofuran-3,3(2H)-dicarboxylate 
(4bj) 
Flash chromatography afforded the title compound (77 mg, 0.18 mmol, 89% yield) as a 
transparent oil, as an inseparable mixture of diastereoisomers; dr = 20:1 determined by 
integration of 1H NMR signals: δminor 6.33 (dd), δmajor 5.97 ppm (dd).  
Rf 0.51 (n-hex/EtOAc 6/4);  
1H NMR (400 MHz, CDCl3) δ 7.93 (dd, 2 H, J = 5.3, 3.0 Hz, Phth), 
7.79 (dd, 2 H, J = 5.3, 3.0 Hz, Phth), 7.37-7.02 (m, 5 H, Ph), 5.97 
(dd, 1 H, J = 10.0, 6.1 Hz, CHNPhth), 4.68 (dd, 1 H, J = 11.2, 2.6 
Hz, CHO), 3.90 (dd, 1 H, J = 13.2, 9.9 Hz, CH2CHNPhth), 3.85 (s, 3 H, OCH3), 3.79 (s, 3 H, 
OCH3), 2.93-2.80 (m, 1 H, CH2Ph), 2.67-2.54 (m, 2 H, CH2CHNPhth+ CH2Ph), 2.43-2.28 (m, 
1 H, CH2CH2Ph), 1.80-1.67 (m, 1 H, CH2CH2Ph);  
13C NMR (101 MHz, CDCl3) δ 170.4, 168.1, 167.3, 141.8, 134.4, 131.8, 128.7, 128.3, 125.8, 
123.7, 80.5, 79.1, 63.6, 53.4, 52.9, 33.6, 33.2, 32.2;  
IR 3028 (w), 2954 (w), 1780 (w), 1720 (s), 1468 (w), 1456 (w), 1436 (w), 1370 (m), 1333 
(w), 1263 (m), 1229 (m), 1205 (m), 1134 (m), 1090 (m), 1074 (m), 1046 (m), 1016 (m), 999 
(w), 973 (m), 943 (w), 914 (m), 876 (w), 796 (w), 720 (s), 702 (m), 684 (w), 673 (m), 658 
(w), 630 (w);  
HRMS (ESI) calcd for C24H24NO7
+ [M+H]+ 438.1547; found 438.1549. 
Diethyl 5-(1,3-dioxoisoindolin-2-yl)-2-isopropyldihydrofuran-3,3(2H)-dicarboxylate 
(4ak) 
Flash chromatography afforded the title compound (80 mg, 0.20 mmol, 99% yield) as a 
transparent oil, as an inseparable mixture of diastereoisomers; dr = 7:1 determined by 
integration of 1H NMR signals: δminor 6.25 (pseudo t), δmajor 5.82 ppm (dd).  
Rf 0.59 (n-hex/EtOAc 6/4);  
1H NMR (cis+trans mixture, 400 MHz, CDCl3) δ 7.89 (dd, 2 H, J = 
5.6, 3.0 Hz, Phth), 7.76 (dd, 2 H, J = 5.6, 3.0 Hz, Phth), 6.25 (pseudo t, 
1 Htrans, J = 7.3 Hz, CHNPhth), 5.82 (dd, 1 Hcis, J = 9.8, 6.1 Hz, 
CHNPhth), 4.77 (d, 1 Htrans, J = 8.2 Hz, CHO), 4.38-4.21 (m, 5 H, 
OCH2CH3 + CHcisO), 3.89 (dd, 1 Hcis, J = 13.2, 9.8 Hz, CH2CHNPhth), 3.13-3.04 (m, 2 
Htrans, CH2CHNPhth), 2.60 (dd, 1 Hcis, J = 13.2, 6.1 Hz, CH2CHNPhth), 2.31 (hept, 1 Hcis, J 





= 6.7 Hz, iPr), 1.88-1.76 (m, 1 Htrans, iPr), 1.37-1.28 (m, 6 H, OCH2CH3), 1.05 (d, 3 Htrans, J = 
6.7 Hz, iPr), 0.98 (d, 3 H, J = 6.7 Hz, i-Pr), 0.95 (d, 3 H, J = 6.7 Hz, iPr);  
13C NMR (101 MHz, CDCl3, cis isomer) δ 170.8, 168.7, 167.3, 134.4, 131.8, 123.6, 86.6, 
78.2, 62.3, 62.2, 61.9, 35.6, 29.6, 20.2, 18.8, 14.0, 13.9;  
IR 2983 (w), 2939 (w), 2909 (w), 2908 (w), 2876 (w), 1781 (w), 1720 (s), 1612 (w), 1470 
(w), 1447 (w), 1369 (s), 1329 (m), 1298 (m), 1262 (m), 1231 (m), 1192 (m), 1141 (m), 1117 
(m), 1092 (m), 1044 (m), 1026 (m), 1017 (m), 1006 (m), 952 (w), 868 (w), 796 (w), 720 (s), 
654 (w), 635 (w);  
HRMS (ESI) calcd for C21H26NO7
+ [M+H]+ 404.1704; found 404.1698. 
Diethyl 2-cyclohexyl-5-(1,3-dioxoisoindolin-2-yl)dihydrofuran-3,3(2H)-dicarboxylate 
(4al) 
Flash chromatography afforded the title compound (79 mg, 0.18 mmol, 90% yield) as a 
transparent oil, as an inseparable mixture of diastereoisomers; dr = 7:1 determined by 
integration of 1H NMR signals: δminor 6.25 (pseudo t), δmajor 5.81 ppm (dd).  
Rf 0.60 (n-hex/EtOAc 6/4);  
1H NMR (cis+trans mixture, 400 MHz, CDCl3) δ 7.89 (dd, 2 H, J = 
5.6, 2.9 Hz, Phth), 7.76 (dd, 2 H, J = 5.6, 2.9 Hz, Phth), 6.25 (pseudo 
t, 1 Htrans, J = 7.3 Hz, CHNPhth), 5.81 (dd, 1 Hcis, J = 9.6, 6.2 Hz, 
CHNPhth), 4.81 (d, 1 Htrans, J = 8.2 Hz, CHO), 4.36-4.20 (m, 5 H, OCH2CH3 + CHcisO), 3.86 
(dd, 1 Hcis, J = 13.2, 9.6 Hz, CH2CHNPhth), 3.08 (pseudo d, 2 Htrans, J = 7.3 Hz, 
CH2CHNPhth), 2.60 (dd, 1 Hcis, J = 13.2, 6.2 Hz, CH2CHNPhth), 2.04-1.93 (m, 1 H, 
cyclohexyl), 1.89-1.77 (m, 1 H, cyclohexyl), 1.77-1.52 (m, 4 H, cyclohexyl), 1.34 (t, 3 H, J = 
7.1 Hz, OCH2CH3), 1.31 (t, 3 H, J = 7.1 Hz, OCH2CH3), 1.27-1.03 (m, 5 H, cyclohexyl);  
13C NMR (101 MHz, CDCl3, cis isomer) δ 170.9, 168.9, 167.3, 134.3, 131.8, 123.6, 85.8, 
78.1, 62.1, 61.8, 39.2, 36.0, 30.4, 28.7, 26.2, 26.1, 25.9, 13.9, 14.0; 6  
IR 2981 (w), 2936 (w), 1782 (w), 1720 (s), 1468 (w), 1452 (w), 1368 (m), 1303 (m), 1258 
(m), 1218 (m), 1195 (m), 1139 (m), 1115 (m), 1090 (m), 1073 (m), 1015 (m), 914 (m), 873 
(m), 763 (m), 720 (s), 651 (m);  
HRMS (ESI) calcd for C24H30NO7
+ [M+H]+ 444.2017; found 444.2019. 
Dimethyl 2-(tert-butyl)-5-(1,3-dioxoisoindolin-2-yl)dihydrofuran-3,3(2H)-dicarboxylate 
(4bm) 
                                                 
[6] Two carbons are overlapping. 





Flash chromatography afforded the title compound (72 mg, 0.19 mmol, 92% yield) as a 
transparent sticky oil, as an inseparable mixture of diastereoisomers; dr = 9:1 determined by 
integration of 1H NMR signals: δminor 6.28 (dd), δmajor 5.67 ppm (dd).  
Crystallization in iPrOH afforded analytically pure cis isomer (dr > 20:1). 
Rf 0.53 (n-hex/EtOAc 6/4);  
Mp 171-173 °C; 
1H NMR (400 MHz, CDCl3) δ 7.90 (dd, 2 H, J = 5.3, 3.0 Hz, Phth), 
7.77 (dd, 2 H, J = 5.3, 3.0 Hz, Phth), 5.67 (dd, 1 H, J = 10.8, 5.4 Hz, 
CHNPhth), 4.49 (s, 1 H, CHO), 4.10 (dd, 1 H, J = 13.0, 10.8 Hz, CH2CHNPhth), 3.84 (s, 3 H, 
OCH3), 3.80 (s, 3 H, OCH3), 2.50 (dd, 1 H, J = 13.0, 5.4 Hz, CH2CHNPhth), 1.02 (s, 9H, 
tBu);  
13C NMR (101 MHz, CDCl3) 171.6, 169.5, 167.4, 134.4, 131.8, 123.7, 88.3, 77.8, 61.4, 53.3, 
52.7, 36.2, 34.7, 26.5;  
IR 2957 (w), 2866 (w), 1783 (w), 1724 (s), 1723 (s), 1467 (w), 1459 (w), 1436 (w), 1374 (m), 
1339 (w), 1266 (m), 1265 (m), 1237 (w), 1236 (w), 1200 (w), 1184 (w), 1183 (w), 1135 (w), 
1082 (w), 1081 (w), 1056 (w), 1055 (w), 1029 (w), 1007 (w), 970 (w), 960 (w), 913 (w), 871 
(w), 721 (m), 673 (w), 659 (w), 651 (w), 635 (w);  
HRMS (ESI) calcd for C20H24NO7
+ [M+H]+ 390.1553; found 390.1563.  
 
3 Enantiospecificity test 
Following the standard procedure for the iron-catalysed [3+2] annulation (S5), using 28 mg 
(0.080 mmol, 1 eq) of enantioenriched aminocyclopropane 2a (er = 99:1), 4 mg of FeCl3-
Al2O3 (4 mol, 5 mol %) and 4 L of benzaldehyde (3a) (0.04 mmol, 0.5 eq), 18 mg (0.040 
mmol, 49 % yield, 99% in relation to aldehyde 3a, racemic) of 4aa were isolated, together 
with 4 mg (0.01 mmol, 14 % yield, racemic) of unreacted 2a (reaction time = 30 min; if the 
reaction time was extended to 2 h, only 4aa was isolated from the crude reaction mixture).  
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6 Crystallographic data 
The crystal structure has been deposited at the Cambridge Crystallographic Data Centre and allocated 
the deposition number : CCDC 855246. 
Table 1.  Crystal data and structure refinement for 4ab. 
Identification code  4ab 
Empirical formula  C25H25.30NO8.15 
Formula weight  470.25 
Temperature  140(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 8.3373(8) Å = 109.268(6)°. 
 b = 10.8545(6) Å = 90.264(7)°. 
 c = 14.1321(5) Å  = 106.447(5)°. 
Volume 1151.07(13) Å3 
Z 2 
Density (calculated) 1.357 Mg/m3 
Absorption coefficient 0.102 mm-1 
F(000) 495 
Crystal size 0.45 x 0.38 x 0.25 mm3 
Theta range for data collection 3.07 to 27.49°. 
Index ranges -10<=h<=10, -13<=k<=14, -18<=l<=18 
Reflections collected 17348 
Independent reflections 5206 [R(int) = 0.0233] 
Completeness to theta = 27.49° 98.7 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7456 and 0.6857 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5206 / 1 / 323 
Goodness-of-fit on F2 1.087 
Final R indices [I>2sigma(I)] R1 = 0.0414, wR2 = 0.0847 
R indices (all data) R1 = 0.0586, wR2 = 0.0939 
Largest diff. peak and hole 0.258 and -0.205 e.Å-3 





 Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (Å2x 103) 
for 4ab.  U(eq) is defined as one third of  the trace of the orthogonalized U ij tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
O(1) 2102(1) 2816(1) 4407(1) 31(1) 
O(2) 6000(1) 1379(1) 5735(1) 33(1) 
O(3) 4680(1) 1491(1) 3145(1) 25(1) 
O(4) 671(1) 1590(1) -690(1) 34(1) 
O(5) 5401(1) 5388(1) 2933(1) 33(1) 
O(6) 7004(1) 4553(1) 1752(1) 25(1) 
O(7) 8967(1) 2767(1) 2746(1) 31(1) 
O(8) 9309(1) 5018(1) 3517(1) 28(1) 
N(1) 4316(2) 2128(1) 4862(1) 26(1) 
C(1) 2694(2) 2297(1) 4905(1) 26(1) 
C(2) 4659(2) 1546(1) 5573(1) 27(1) 
C(3) 3070(2) 1228(1) 6047(1) 29(1) 
C(4) 2662(2) 537(2) 6725(1) 36(1) 
C(5) 1030(3) 327(2) 7003(1) 43(1) 
C(6) -123(2) 814(2) 6632(1) 43(1) 
C(7) 298(2) 1515(2) 5952(1) 35(1) 
C(8) 1914(2) 1695(1) 5665(1) 29(1) 
C(9) 5468(2) 2384(1) 4140(1) 24(1) 
C(10) 5440(2) 2057(1) 2405(1) 22(1) 
C(11) 6513(2) 3584(1) 3029(1) 21(1) 
C(12) 5915(2) 3814(1) 4081(1) 25(1) 
C(13) 4101(2) 1887(1) 1603(1) 22(1) 
C(14) 2511(2) 1996(1) 1826(1) 24(1) 
C(15) 1320(2) 1881(1) 1078(1) 25(1) 
C(16) 1727(2) 1672(1) 94(1) 25(1) 
C(17) 3312(2) 1545(2) -145(1) 29(1) 
C(18) 4474(2) 1639(1) 603(1) 26(1) 
C(19) -963(2) 1721(2) -477(1) 38(1) 
C(20) 6219(2) 4623(1) 2585(1) 22(1) 
C(21) 6810(2) 5475(2) 1233(1) 33(1) 
C(22) 7472(2) 5031(2) 230(1) 39(1) 
C(23) 8393(2) 3709(1) 3066(1) 22(1) 
C(24) 11133(2) 5344(2) 3455(1) 34(1) 





C(25) 11534(2) 5609(2) 2491(1) 39(1) 
O(9) 3779(9) -1460(7) 2115(6) 35(3) 
________________________________________________________________________________ 





 Table 3.   Bond lengths [Å] and angles [°] for  4ab. 
_____________________________________________________  
O(1)-C(1)  1.2140(18) 
O(2)-C(2)  1.2146(19) 
O(3)-C(9)  1.4418(16) 
O(3)-C(10)  1.4444(16) 
O(4)-C(16)  1.3760(18) 
O(4)-C(19)  1.4321(19) 
O(5)-C(20)  1.2048(16) 
O(6)-C(20)  1.3407(17) 
O(6)-C(21)  1.4628(16) 
O(7)-C(23)  1.2051(16) 
O(8)-C(23)  1.3390(16) 
O(8)-C(24)  1.4710(18) 
N(1)-C(1)  1.4138(19) 
N(1)-C(2)  1.4164(18) 
N(1)-C(9)  1.4445(18) 
C(1)-C(8)  1.494(2) 
C(2)-C(3)  1.492(2) 
C(3)-C(8)  1.389(2) 
C(3)-C(4)  1.389(2) 
C(4)-C(5)  1.395(3) 
C(4)-H(4)  0.9500 
C(5)-C(6)  1.395(3) 
C(5)-H(5)  0.9500 
C(6)-C(7)  1.400(2) 
C(6)-H(6)  0.9500 
C(7)-C(8)  1.387(2) 
C(7)-H(7)  0.9500 
C(9)-C(12)  1.5211(19) 
C(9)-H(9)  1.0000 
C(10)-C(13)  1.515(2) 
C(10)-C(11)  1.5854(18) 
C(10)-H(10)  1.0000 
C(11)-C(20)  1.5310(19) 
C(11)-C(23)  1.5335(19) 
C(11)-C(12)  1.5351(19) 
C(12)-H(12A)  0.9900 





C(12)-H(12B)  0.9900 
C(13)-C(14)  1.3923(19) 
C(13)-C(18)  1.4023(19) 
C(14)-C(15)  1.398(2) 
C(14)-H(14)  0.9500 
C(15)-C(16)  1.392(2) 
C(15)-H(15)  0.9500 
C(16)-C(17)  1.399(2) 
C(17)-C(18)  1.390(2) 
C(17)-H(17)  0.9500 
C(18)-H(18)  0.9500 
C(19)-H(19A)  0.9800 
C(19)-H(19B)  0.9800 
C(19)-H(19C)  0.9800 
C(21)-C(22)  1.500(2) 
C(21)-H(21A)  0.9900 
C(21)-H(21B)  0.9900 
C(22)-H(22A)  0.9800 
C(22)-H(22B)  0.9800 
C(22)-H(22C)  0.9800 
C(24)-C(25)  1.503(2) 
C(24)-H(24A)  0.9900 
C(24)-H(24B)  0.9900 
C(25)-H(25A)  0.9800 
C(25)-H(25B)  0.9800 
C(25)-H(25C)  0.9800 
O(9)-H(9A)  1.00(10) 
































































































































Symmetry transformations used to generate equivalent atoms:  
  





 Table 4.   Anisotropic displacement parameters  (Å2x 103) for 4ab.  The anisotropic 
displacement factor exponent takes the form:  -22[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
O(1) 37(1)  29(1) 32(1)  14(1) 10(1)  12(1) 
O(2) 40(1)  28(1) 31(1)  11(1) -2(1)  7(1) 
O(3) 35(1)  18(1) 21(1)  8(1) 4(1)  3(1) 
O(4) 34(1)  38(1) 29(1)  12(1) 0(1)  10(1) 
O(5) 35(1)  25(1) 41(1)  10(1) 8(1)  16(1) 
O(6) 27(1)  23(1) 30(1)  15(1) 5(1)  9(1) 
O(7) 29(1)  24(1) 42(1)  10(1) 6(1)  12(1) 
O(8) 26(1)  22(1) 33(1)  5(1) -1(1)  5(1) 
N(1) 34(1)  22(1) 24(1)  10(1) 9(1)  9(1) 
C(1) 35(1)  18(1) 24(1)  6(1) 7(1)  6(1) 
C(2) 41(1)  15(1) 21(1)  4(1) 3(1)  5(1) 
C(3) 44(1)  17(1) 21(1)  4(1) 7(1)  6(1) 
C(4) 62(1)  23(1) 24(1)  9(1) 12(1)  11(1) 
C(5) 74(1)  24(1) 30(1)  11(1) 23(1)  9(1) 
C(6) 55(1)  25(1) 38(1)  5(1) 27(1)  4(1) 
C(7) 44(1)  23(1) 34(1)  6(1) 16(1)  8(1) 
C(8) 41(1)  17(1) 24(1)  5(1) 10(1)  5(1) 
C(9) 30(1)  21(1) 20(1)  6(1) 7(1)  7(1) 
C(10) 26(1)  16(1) 22(1)  6(1) 7(1)  6(1) 
C(11) 24(1)  17(1) 21(1)  5(1) 4(1)  6(1) 
C(12) 31(1)  19(1) 23(1)  5(1) 9(1)  6(1) 
C(13) 26(1)  14(1) 23(1)  5(1) 5(1)  4(1) 
C(14) 29(1)  20(1) 22(1)  7(1) 9(1)  6(1) 
C(15) 25(1)  22(1) 28(1)  7(1) 8(1)  7(1) 
C(16) 29(1)  19(1) 25(1)  7(1) 1(1)  4(1) 
C(17) 32(1)  29(1) 21(1)  7(1) 8(1)  7(1) 
C(18) 25(1)  23(1) 25(1)  5(1) 8(1)  5(1) 
C(19) 33(1)  36(1) 45(1)  14(1) -2(1)  12(1) 
C(20) 20(1)  16(1) 27(1)  6(1) 1(1)  3(1) 
C(21) 38(1)  29(1) 40(1)  22(1) 4(1)  12(1) 
C(22) 48(1)  38(1) 41(1)  26(1) 8(1)  13(1) 
C(23) 27(1)  22(1) 18(1)  9(1) 3(1)  7(1) 
C(24) 23(1)  29(1) 47(1)  10(1) -7(1)  5(1) 





C(25) 28(1)  35(1) 52(1)  14(1) 9(1)  9(1) 
O(9) 36(5)  30(4) 34(5)  12(3) -9(3)  1(3) 
______________________________________________________________________________ 





 Table 5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 3) 
for 4ab. 
________________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________________  
  
H(4) 3457 221 6986 43 
H(5) 698 -158 7455 52 
H(6) -1218 668 6846 51 
H(7) -483 1851 5699 42 
H(9) 6522 2180 4282 29 
H(10) 6227 1543 2073 26 
H(12A) 6820 4469 4614 30 
H(12B) 4922 4152 4138 30 
H(14) 2232 2151 2498 29 
H(15) 235 1945 1239 30 
H(17) 3593 1395 -816 34 
H(18) 5541 1534 435 31 
H(19A) -1590 972 -256 57 
H(19B) -1571 1680 -1088 57 
H(19C) -846 2599 57 57 
H(21A) 7452 6432 1632 39 
H(21B) 5610 5417 1138 39 
H(22A) 8664 5109 335 59 
H(22B) 7346 5617 -147 59 
H(22C) 6838 4078 -152 59 
H(24A) 11519 4569 3477 41 
H(24B) 11731 6163 4038 41 
H(25A) 11006 4774 1915 58 
H(25B) 12755 5879 2472 58 
H(25C) 11101 6345 2457 58 
H(9A) 4180(160) -440(110) 2360(100) 52 
H(9B) 3580(160) -1700(130) 2740(90) 52 
________________________________________________________________________________ 


































































































Symmetry transformations used to generate equivalent atoms:  
  





 Table 7.  Hydrogen bonds for 4ab  [Å and °]. 
____________________________________________________________________________  
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
____________________________________________________________________________  
 O(9)-H(9A)...O(3) 1.00(10) 1.94(11) 2.914(7) 165(11) 
 O(9)-H(9B)...O(2)#1 1.00(10) 2.08(11) 3.013(8) 155(11) 
____________________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
#1 -x+1,-y,-z+1       
    
 
